BIOCHEMICAL AND GENETIC FACTORS REGULATING DILANTIN METABOLISM IN MAN*

10.1126/science.85.2213.525

10.7326/0003-4819-67-5-1084

10.1161/01.CIR.38.2.363

10.1097/00000441-196607000-00009

Itil T. M., 1967, Study of behavior and EEG correlation during treatment of disturbed children, Dis. Nerv. Syst., 28, 731

10.1001/archneur.1960.03840120030004

Kutt H., 1968, Management of epilepsy with diphenylhydantoin sodium, J.A.M.A., 203, 969, 10.1001/jama.1968.03140110061012

Haerer A. F., 1969, Studies of anticonvulsant levels in epileptics, Acta Neurol. Scand., 48, 18

10.1055/s-0028-1111205

10.1001/archneur.1964.00460240074010

10.1001/archneur.1968.00470350030002

10.1111/j.1528-1157.1959.tb04274.x

Svensmark O., 1963, Dosage of phenytoin and phenobarbital in children, Danish Med. Bull., 10, 234

10.1111/j.1528-1157.1964.tb03342.x

10.1111/j.1528-1157.1964.tb04345.x

10.1001/archneur.1968.00470350023001

Noach E. L., 1958, Studies on the absorption, distribution, fate and excretion of 4‐C14‐labeled diphenylhydantoin, J. Pharmacol. Exp. Ther., 122, 301

10.1111/j.1528-1157.1969.tb03839.x

Butler T. C., 1957, Metabolic conversion of 5‐5‐diphenylhydantoin to 5′‐(p‐hydroxyphenyl)‐5 phenylhydantoin, J. Pharmacol. Exp. Ther., 119, 1

Maynert E. W., 1960, The metabolic fate of diphenylhydantoin in the dog, rat and man, J. Pharmacol. Exp. Ther., 130, 275

10.1002/cpt1969104498

Olesen V., 1969, Drug‐interaction between sulthiame (Ospolot) and phenytoin in the treatment of epilepsy, Danish Med. Bull., 16, 154

Verebely K., 1970, The metabolite patterns of C14 diphenylhydantoin in the human and the rat, Fed. Proc., 29, 29

Chang T., 1970, A dihydrodiol metabolite of 5–5 diphenylhydantoin (Dilantin; phenytoin; DPH), Fed. Proc., 29, 29

10.1001/archneur.1966.00470110033004

10.1002/cpt196564420

10.1111/j.0954-6820.1969.tb07346.x

Buchanan R. A., 1969, The effect of phenobarbital on diphenylhydantoin metabolism in children, Pediatrics., 43, 114, 10.1542/peds.43.1.114

Garattini S.This monograph.

10.1212/WNL.19.6.611

Cucinell S. A., 1963, Stimulatory effect of phenobarbital on the metabolism of diphenylhydantoin, J. Pharmacol. Exp. Ther., 141, 157

Kutt H., 1970, Diphenylhydantoin metabolism by rat liver microsomes and some of the effects of drug or chemical pretreatment on diphenylhydantoin metabolism by rat liver microsomal preparations, J. Pharmacol. Exp. Ther.

Conney A. H., 1967, Pharmacological implications of microsomal enzyme induction, Pharmacol. Rev., 19, 317

10.1016/0006-2952(69)90151-8

Gerber N., 1969, Studies on the metabolism of diphenylhydantoin in mice, J. Pharmacol. Exp. Ther., 167, 77

Eling T. E., 1970, Diphenylhydantoin effect on neonatal and adult rat hepatic drug metabolism, J. Pharmacol. Exp. Ther., 171, 127

10.1212/WNL.14.6.542

10.1001/archneur.1964.00460240081011

10.1016/S0022-3476(70)80383-3

Mellk H. J. M.Letteri S.Louis H.Kutt P.Durante&A. J.Glazko.Diphenylhydantoin metabolism in uremia.In preparation.

10.1016/S0140-6736(66)92547-5

10.1111/j.1528-1157.1966.tb03803.x

10.1001/archneur.1967.00470240080011

10.1002/cpt196784554

10.1212/WNL.16.6.594

Murray F. J., 1962, Outbreak of unexpected reactions among epileptics taking isoniazid, Amer. Rev. Resp. Dis., 82, 82

Dold U., 1969, Akute Leberzellschädigung durch gleichzeitige Gabe von Diphenylhydantoin und INH, Vortrag vor dem Med.-Naturw. Verein Tübingen

10.1055/s-0028-1111205

10.1111/j.1528-1157.1968.tb04954.x

10.1001/jama.207.11.2053

10.1016/0006-2952(70)90230-3

10.1212/WNL.15.9.823

Kutt H., 1970, Diphenylhydantoin intoxication: a complication of isoniazid therapy, Amer. Rev. Resp. Dis., 101, 377

10.1212/WNL.18.7.706

10.1212/WNL.20.7.687

Evans D. A. P., 1960, The determination of the isoniazid inactivator phenotype, Amer. Rev. Resp. Dis., 82, 82

10.1136/bmj.2.5197.485

Evans D. A. P., 1965, Individual variations of drug metabolism as a factor in drug toxicity, Ann. N.Y. Acad. Sci., 123, 123

10.1016/S0140-6736(69)90937-4

10.1177/009127007001000503

10.1172/JCI106186